Importance: To date, 29 states and the District of Columbia have legalized the use of marijuana for medicinal purposes. Although there is increasing concern that legalizing medical marijuana will make workplaces more dangerous, little is known about the relationship between medical marijuana laws (MMLs) and workplace fatalities.
INTRODUCTION
Although marijuana remains illegal under federal law, 29 states and the District of Columbia have passed laws legalizing its use for medicinal purposes. 1 Medical marijuana laws (hereafter MMLs) remove state-level penalties for using and possessing marijuana for medical purposes. Patients are required to obtain approval or certification from a physician, and physicians who recommend marijuana to their patients are immune from criminal prosecution.
Increasingly, concerns are being raised over the potential impact of MMLs on workplace safety. [2] [3] [4] [5] As a backdrop to these concerns, there are important legal issues surrounding workplace safety and the use of medical marijuana that remain unresolved. For instance, in many states it is unclear whether employers can impose sanctions on registered medical marijuana patients who test positive for tetrahydrocannabinol (THC), the active ingredient in marijuana, or whether insurance companies can claim marijuana as the cause of injury or death in the workplace. [6] [7] [8] There is strong evidence that legalizing medical marijuana leads to a decrease in the price of marijuana and an increase in its consumption. [9] [10] [11] However, the association between legalization and workplace safety could, in theory, be negative or positive. On the one hand, extensive research has demonstrated that there are important short-term effects of marijuana use on psychomotor performance and cognition that could lead to more on-the-job accidents, including impairments in memory function, information processing, hand-eye coordination, and reaction times. [12] [13] [14] [15] On the other hand, previous studies have found that the legalization of medical marijuana leads to substantial reductions in the consumption of alcohol, opioids and other substances, 9, [16] [17] [18] [19] , which could lead to safer workplaces and fewer accidents.
Drawing on data at the state-year level collected by the Bureau of Labor Statistics for the period 1992-2015, the relationship between legalizing medical marijuana and workplace fatalities was examined. Multivariate Poisson regression analysis was used to adjust for demographics, income, the unemployment rate, legalization of recreational marijuana, decriminalization of marijuana, state fixed effects, and year fixed effects. No previously published study has examined the relationship between MMLs and workplace fatalities.
METHODS
Panel data on workplace fatalities at the state-year level came from Census of Fatal
Occupational Injuries (CFOI). These data are produced by the Occupational Safety and Health
Statistics (OSHS) program, which is administered by the Bureau of Labor Statistics (BLS). The
CFOI provides counts of all fatal work injuries occurring in the U.S. during each calendar year.
The OSHS program uses diverse state, federal, and independent data sources to identify, verify, and describe fatal work injuries, ensuring that counts are as complete and accurate as possible.
The CFOI data are publicly available from the BLS for the period under study, 1992-2015, and have been used by previous researchers interested in the determinants of workplace saftey. [20] [21] [22] Total workplace fatality counts by state and year, as well as counts for different age groups are Following previous studies in this area of research 9-11, 16-17, 19 , 50 state indicators were included as covariates in the regression analysis. Their inclusion on the right-hand side of the regression model accounted for the influence of time-invariant factors at the state level (i.e., state "fixed effects") such as rules and regulations pertaining to workplace safety and ensured that estimates of the association between legalizing medical marijuana and workplace fatalities were identified using only within-state variation over time. Again, following previous studies in this area of research 9-11, 16-17, 19 , 23 year indicators were included to account for year-to-year changes in workplace fatalities that were common across all 50 states and the District of Columbia due to, for instance, changes in federal regulations or technology.
Estimated IRRs were also adjusted for within-state changes over time in demographics (percent of the population white, percent black, and percent over the age of 18), per-capita income, the unemployment rate, the legalization of recreational marijuana, and the decriminalization of marijuana. There is evidence that workplace accidents are generally procyclical 26 , while the effects of legalizing recreational marijuana and decriminalizing marijuana could be similar to the effects of legalizing medical marijuana. Information on MMLs, whether the use of recreational marijuana was legal, and the decriminalization of marijuana came from a variety of published sources. 1, [27] [28] The state unemployment rate and per-capita income came from the Bureau of Labor Statistics and the Bureau of Economic Analysis, respectively.
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Means of workplace fatalities and the covariates are reported in Table 2 .
Several extensions of the basic multivariate Poisson regression model described above were also estimated. Specifically, the expected number of workplace fatalities was replaced by the expected number of workplace fatalities for the following age groups: 16-24, 25-44, 45-64, and 65+. Previous studies provide evidence that legalizing medical marijuana has larger effects on marijuana consumption among young adults than among adolescents or older adults. 10, [31] [32] [33] In addition, regressions were run allowing the association between MMLs and workplace fatalities to vary according to whether pain was included as a qualifying condition and whether collective cultivation was allowed. Critics of legalizing medical marijuana contend that including chronic or severe pain as a qualifying condition encourages recreational use by registered patients, 23 while there is evidence that the effect of MMLs on substance use is strongest when collective cultivation is allowed. 9, 19, 34 Finally, estimates of the association between MMLs and workplace fatalities were allowed to vary according to the time elapsed since implementation to account for delays in patient registration and the opening of dispensaries. These estimates were used to produce an event-study figure, which allowed an examination of pre-treatment trends in workplace fatalities. There is evidence that the effect of MMLs on substance use is weakest immediately after implementation, becoming steadily stronger thereafter.
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RESULTS
The association between legalizing medical marijuana and total workplace fatalities, although negative, was not statistically significant at conventional levels (Table 3) . By contrast, legalizing medical marijuana was associated with a 19.5% reduction in the expected number of workplace fatalities among workers aged 25-44 (IRR, .805; 95% CI, .662-.979) after adjusting for the covariates listed in Table 2 , state fixed effects, and year fixed effects. This negative association was robust to including state-specific linear trends in the model. The association between MMLs and workplace fatalities among workers aged 16-24, although negative, was not statistically significant. Likewise, the association between MMLs and workplace fatalities among workers aged 45 and over was negative but not statistically significant at the 5% level.
The negative association between legalizing medical marijuana and workplace fatalities among workers aged 25-44 was strongest if pain was included as a qualifying condition ( Prior to the year of implementation (year 0), there was no evidence of an association between MMLs and workplace fatalities among workers aged 25-44 after adjusting for the covariates listed in Table 2 , state fixed effects, and year fixed effects (Figure 1 ). After implementation, the negative association between MMLs and workplace fatalities among workers aged 25-44 gained strength over time. In the first 4 years after implementation, the association between legalization and workplace fatalities was relatively small and not statistically significant. For instance, one year after implementation the IRR was 1.01 [95% CI,
.903-1.14], and three years after implementation the IRR was .861 [95% CI, .741-1.00].
However, 5 or more years after implementation, the association between MMLs and workplace fatalities was negative, larger in absolute magnitude, and statistically significant. Specifically, legalizing medical marijuana was associated with a 33.7% reduction in the expected number of workplace fatalities among workers aged 25-44 (IRR, .663; 95% CI, .482-.912).
DISCUSSION
MMLs protect patients from criminal prosecution, but the use of medical marijuana in the workplace is generally not protected. Several states (e.g., Colorado, Michigan, Oregon, Washington) have ruled that employers may discipline employees or terminate their employment following a positive drug test because MMLs are not intended to address employment issues. [6] [7] Although some MMLs explicitly protect employees from termination due to a positive drug test, employers and insurance companies continue to argue in court that the use of medical marijuana violates zero-tolerance drug policies and compromises workplace safety. 4, [6] [7] [8] Unresolved legal issues notwithstanding, it is clear that workplace injuries impose substantial costs on society. In 2015, the latest year for which statistics are available, there were a total of 4,836 fatal on-the-job injuries in the United States. 35 The causes of these injuries are myriad, ranging from homicide, to motor vehicle accidents, to electrocution, to being crushed by machinery. 35 Given their frequency, any estimate of the cost of legalizing medical marijuana is likely to be inaccurate if workplace fatalities are not taken into account.
Legalizing the use of medical marijuana should unambiguously lead to an increase in the consumption of marijuana. [36] [37] By contrast, the association between legalization and workplace safety could, in theory, be either negative or positive. Marijuana use impairs memory function, information processing, hand-eye coordination, and reaction times [12] [13] [14] [15] , all of which could plausibly result in more on-the-job accidents and workplace fatalities. Indeed, a number of epidemiological studies provide evidence of a positive association between marijuana use and the likelihood of being involved in a motor vehicle accident 38 , one of the leading causes of onthe-job injury in the United States. 35 However, other studies show that the legalization of medical marijuana is associated with substantial reductions in the consumption of alcohol, opioids and other substances. 9, [16] [17] [18] [19] For instance, Anderson et al. found that legalization of medical marijuana was associated with a 5% reduction in beer sales 9 , while Bachhuber et al. found that legalization of medical marijuana was associated with a 20% to 33% decrease in deaths involving opioids. 16 Because the use of alcohol at work is associated with a substantial increase in the risk of injury [39] [40] , and because nonhabitual opioid use slows reflexes and impairs cognitive functioning 41 , the enactment of MMLs could, in theory, make workplaces safer.
Traffic fatalities, the abuse of other substances, suicides, and crime are among the costs of legalizing medical marijuana considered by previous researchers. 9, 11, 16, [42] [43] [44] [45] The current study, however, is the first to examine the association between MMLs and workplace fatalities.
Using data from the BLS and a multivariate Poisson regression model, a negative association between MMLs and fatalities among workers aged 25-44 was found after adjusting for state demographics, the unemployment rate, the decriminalization of marijuana, the legalization of recreational marijuana, state fixed effects, and year fixed effects.
The negative association between MMLs and workplace fatalities among workers aged 25-44 was robust to including state-specific linear trends in the model, suggesting that it cannot be explained by slowly evolving, but difficult-to-measure factors at the state level such as attitudes or health behaviors. 16 The association between MMLs and workplace fatalities among workers aged 16-24, although negative, was not statistically significant. Likewise, the association between MMLs and workplace fatalities among worker above the age of 44 was not statistically significant. This general pattern of results is not surprising given that previously published research suggests that young adults respond to the legalization of medical marijuana by consuming substantially less alcohol, 9, 19 while any response to legalizing medical marijuana on the part of teenagers and older adults has been difficult to isolate from year-to-year fluctuations in substance use. 9-10, 19, 31-33 Two studies provide evidence that MMLs passed in the 1990s and early 2000s led to higher enrollment rates and greater marijuana consumption than did newer "medicalized" medical marijuana programs. 23, 46 Consistent with these findings, the negative association between MMLs and workplace fatalities among adults aged 25-44 was stronger in states that included severe or chronic pain as a qualifying condition. Consistent with the argument that diversion to the recreational market can be limited by prohibiting home growing and limiting caregivers to one patient 24 , the negative association between MMLs and workplace fatalities among adults aged 25-44 was stronger in states that allowed collective cultivation. Finally, consistent with the parallel trends assumption, there was no evidence of any association between
MMLs and workplace fatalities among workers aged 25-44 in the years leading up to implementation. However, the negative association between MMLs and workplace fatalities gradually became larger in magnitude after implementation.
This study has several limitations that deserve mention. First, the data are at the state as opposed to the individual level. Access to detailed individual-level data collected by the BLS would allow us to explore who precisely was affected by MMLs and would allow us to describe the nature of their injuries. Access to individual-level data could also improve the precision of the estimates and would allow us to explore the association between MMLs and workplace fatalities in specific industries or occupations by age (e.g., young adults working in mining, young adults working in construction, etc.). The negative associations between MMLs and workplace fatalities found for other age groups (i.e., workers aged 16-24, workers aged 45-64, and workers over the age of 64) were not statistically significant. Using individual-level data would allow us to adjust for other factors (e.g., marital status, educational attainment, occupation) and could produce more precise estimates of these associations.
Second, the estimates provided in Tables 3 and 4 demonstrate a negative association between MMLs and workplace fatalities among adults aged 25-44, but it is not clear why this negative association exists. This negative association could be the result of workers responding to the legalization of medical marijuana by reducing their use of other substances (e.g., alcohol
and prescription opioids). It is also possible that this negative association is due to other, often more-difficult-to-document, effects of THC. For instance, drivers under the influence of THC appear to take fewer risks 2 , which could reduce fatal accidents among, for instance, truck drivers and other transportation workers. Consistent with the argument that workers are healthier, and perhaps less prone to being involved in an accident, the legalization of medical marijuana has been linked to fewer sickness-related absences from work. 47 In the absence of detailed data on drug and alcohol use by workers involved in accidents, it will be difficult to distinguish between these various potential mechanisms.
Third, and finally, the inclusion of state fixed effects in our regression models accounted for the influence of time-invariant factors that could be correlated with MMLs and workplace fatalities. However, it is possible that there were difficult-to-observe factors at the state level and workplace safety. The current study is the first to explore the effects of medical marijuana laws on workplace fatalities. Our results suggest that legalizing medical marijuana leads to a reduction in workplace fatalities among workers aged 25-44. This reduction may be the result of workers substituting marijuana in place of alcohol and other substances that can impair cognitive function and motor skills; however, it is important to note that we cannot rule out other potential mechanisms. As the debate over legalization of medical and recreational marijuana continues, it is important that we learn more about the effects of MMLs on workplace safety. Table 2 , 50 state indicators, and 23 year indicators. Ninety-five % confidence intervals are in brackets. N = 1,224.
